Skip to content
We’ve expanded our free plan so you can explore more of Valuesider. Check out the updated pricing page to see what’s now available for free!
User

Meritage Group AGN-OLD trades

Nathaniel Simons

Nathaniel Simons ALLERGAN INC/UNITED STATES stake

total: 301

Trades details

Total transactions:
2
New positions:
1
Sold out:
1
Held since:
2014 Q3
Held for:
1 quarter
Latest activity:
2014 Q4
According to 2026 Q2 report, Nathaniel Simons doesn't hold any ALLERGAN INC/UNITED STATES (AGN-OLD) shares. To date, the estimated cost basis is nearly $178.19 for "buy" trades and estimated average "sell" price is $178.19. Meritage Group first purchased AGN-OLD in 2014 Q3, initially acquiring 424,030 shares. Since the initial investment in ALLERGAN INC/UNITED STATES (AGN-OLD), Meritage Group has made 1 more transaction.

When did Nathaniel Simons sell ALLERGAN INC/UNITED STATES (AGN-OLD)?

Nathaniel Simons sold off the entire ALLERGAN INC/UNITED STATES (AGN-OLD) position in 2014 Q4.

When did Nathaniel Simons buy ALLERGAN INC/UNITED STATES (AGN-OLD)?

Nathaniel Simons first invested in ALLERGAN INC/UNITED STATES (AGN-OLD) in 2014 Q3 at the reported quarter-end price of $178.19 per share.

What's the cost basis of Meritage Group's AGN-OLD stake?

The estimated cost basis for ALLERGAN INC/UNITED STATES (AGN-OLD) stake is around $178.19 per share. This represents their average reported price* across all buy transactions

Estimated cost basis*

Weighted AVG buy price:
$178.19
Weighted AVG sell price:
$178.19

Nathaniel Simons's historical trades in ALLERGAN INC/UNITED STATES

2 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2014 Q4
0.00%
$178.19
-100% (-424,030)
2014 Q3
2.06%
$178.19
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.